Eduardo Dunayevich

Eduardo Dunayevich

Amgen Inc - Thousand Oaks / United States
Medical and Health Sciences / Psychiatry
AD Scientific Index ID: 4425027
-
person_outline Eduardo Dunayevich's MOST POPULAR ARTICLES
1-) Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFL Greenway, K Fujioka, RA Plodkowski, S Mudaliar, M Guttadauria, ...The Lancet 376 (9741), 595-605, 20108562010
2-) A randomized, phase 3 trial of naltrexone SR/bupropion SR on weight and obesity‐related risk factors (COR‐II)CM Apovian, L Aronne, D Rubino, C Still, H Wyatt, C Burns, D Kim, ...Obesity 21 (5), 935-943, 20135362013
3-) Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR‐BMOD trialTA Wadden, JP Foreyt, GD Foster, JO Hill, S Klein, PM O\\\\\\\'neil, MG Perri, ...Obesity 19 (1), 110-120, 20114842011
4-) Rational design of a combination medication for the treatment of obesityFL Greenway, MJ Whitehouse, M Guttadauria, JW Anderson, RL Atkinson, ...Obesity 17 (1), 30-39, 20094032009
5-) The cost of treating anxiety: the medical and demographic correlates that impact total medical costsMD Marciniak, MJ Lage, E Dunayevich, JM Russell, L Bowman, ...Depression and anxiety 21 (4), 178-184, 20052872005